X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (24) 24
female (17) 17
melanoma (17) 17
middle aged (14) 14
oncology (14) 14
male (13) 13
aged (12) 12
cancer (12) 12
adult (11) 11
metastasis (11) 11
mutation (11) 11
survival (9) 9
aged, 80 and over (8) 8
care and treatment (8) 8
analysis (7) 7
chemotherapy (7) 7
clinical trials (7) 7
melanoma - genetics (7) 7
research (7) 7
hematology, oncology and palliative medicine (6) 6
immunotherapy (6) 6
melanoma - drug therapy (6) 6
mutations (6) 6
adolescent (5) 5
dabrafenib (5) 5
disease-free survival (5) 5
double-blind (5) 5
medical research (5) 5
patients (5) 5
prognosis (5) 5
studies (5) 5
survival rate (5) 5
treatment outcome (5) 5
tumors (5) 5
vemurafenib (5) 5
young adult (5) 5
abridged index medicus (4) 4
cancer therapies (4) 4
cobimetinib (4) 4
complications and side effects (4) 4
creatine (4) 4
creatine kinase (4) 4
drug therapy (4) 4
kinases (4) 4
medicine, experimental (4) 4
medicine, general & internal (4) 4
mek inhibition (4) 4
melanoma - metabolism (4) 4
melanoma - pathology (4) 4
prevention (4) 4
prophylaxis (4) 4
review (4) 4
risk factors (4) 4
safety (4) 4
skin (4) 4
skin cancer (4) 4
skin neoplasms - genetics (4) 4
skin neoplasms - pathology (4) 4
trametinib (4) 4
alanine (3) 3
alanine transaminase (3) 3
animals (3) 3
braf (3) 3
breast-cancer (3) 3
cohort studies (3) 3
dermatology (3) 3
development and progression (3) 3
double-blind method (3) 3
follow-up studies (3) 3
hematology (3) 3
improved survival (3) 3
malignant-melanoma (3) 3
medicine, research & experimental (3) 3
metastases (3) 3
metastatic melanoma (3) 3
neoplasm staging (3) 3
neoplasms - drug therapy (3) 3
neoplasms - immunology (3) 3
pathology (3) 3
patient outcomes (3) 3
proto-oncogene proteins b-raf - genetics (3) 3
risk (3) 3
therapy (3) 3
thromboembolism (3) 3
thrombosis (3) 3
3126 surgery, anesthesiology, intensive care, radiology (2) 2
acellular dermal matrix (2) 2
adenocarcinoma (2) 2
algorithms (2) 2
anticoagulants (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
arthralgia (2) 2
biochemistry, genetics and molecular biology (2) 2
biomarkers, tumor - metabolism (2) 2
biotechnology (2) 2
case-control studies (2) 2
cisplatin (2) 2
cisplatin - adverse effects (2) 2
clinical medicine (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 444 - 451
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 436 - 444
Summary Background The orally available BRAF kinase inhibitor vemurafenib, compared with dacarbazine, shows improved response rates, progression-free survival... 
Hematology, Oncology and Palliative Medicine
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 435 - 445
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 10, pp. 943 - 949
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 74, Issue 2, pp. 325 - 332
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2017, Volume 70, Issue 1, pp. 145 - 150
Journal Article
by Shitara, Kohei and Özgüroğlu, Mustafa and Bang, Yung-Jue and Di Bartolomeo, Maria and Mandalà, Mario and Ryu, Min-Hee and Fornaro, Lorenzo and Olesiński, Tomasz and Caglevic, Christian and Chung, Hyun C and Chung, Hyun Cheol and Muro, Kei and Goekkurt, Eray and Mansoor, Wasat and McDermott, Raymond S and Shacham-Shmueli, Einat and Chen, Xinqun and Chen, Jen-Shi and Mayo, Carlos and Kang, S Peter and Ohtsu, Atsushi and Fuchs, Charles S and Lerzo, Guillermo and O'Connor, Juan Manuel and Mendez, Guillermo Ariel and Lynam, James and Tebbutt, Niall and Wong, Mark and Strickland, Andrew and Karapetis, Chris and Goldstein, David and Vasey, Paul and Van Laethem, Jean-Luc and Van Cutsem, Eric and Berry, Scott and Vincent, Mark and Muller, Bettina and Rey, Felipe and Zambrano, Angela and Guerra, Joaquin and Krogh, Merete and Baeksgaard, Lene and Yilmaz, Mette and Elme, Anneli and Magi, Andrus and Auvinen, Paivi and Alanko, Tuomo and Moehler, Markus and Kunzmann, Volker and Seufferlein, Thomas and Thuss-Patience, Peter and Hoehler, Thomas and Haag, Georg and Al-Batran, Salah-Eddin and Castro, Hugo and Lopez, Karla and Aguilar Vasquez, Mynor and Sandoval, Mario and Lam, Ka On and Cuffe, Sinead and Kelly, Cathy and Geva, Ravit and Hubert, Ayala and Beny, Alex and Brenner, Baruch and Giuseppe, Aprile and Falcone, Alfredo and Maiello, Evaristo and Passalacqua, Rodolfo and Montesarchio, Vincenzo and Hara, Hiroki and Chin, Keisho and Nishina, Tomohiro and Komatsu, Yoshito and Machida, Nozumo and Hironaka, Shuichi and Satoh, Taroh and Tamura, Takao and Sugimoto, Naotaoshi and Cho, Haruhiko and Omuro, Yashushi and Kato, Ken and Goto, Masahiro and Hyodo, Ichinosuke and Yoshida, Kazuhiro and Baba, Hideo and Esaki, Taito and Furuse, Junji and Wan Mohammed, Wan Zamaniah and Hernandez Hernandez, Carlos and Casas Garcia, Juan and Dominguez Andrade, Adriana and Clarke, Katriona and Hjortland, Geir and Glenjen, Nils and Kubiatowski, Tomasz and Jacek, Jassem and Wojtukiewicz, Marek and Lazarev, Sergey and Lancukhay, Yuri and ... and KEYNOTE-061 Investigators and KEYNOTE-061 investigators
The Lancet, ISSN 0140-6736, 07/2018, Volume 392, Issue 10142, pp. 123 - 133
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2019, Volume 20, Issue 10, pp. e566 - e581
SummaryVenous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at a high risk of VTE recurrence and... 
Hematology, Oncology, and Palliative Medicine
Journal Article